SEARCH

SEARCH BY CITATION

REFERENCES

  • Alpert NM, Badgaiyan RD, Livni E, Fischman AJ (2003): A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. Neuroimage 19:10491060.
  • Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA (2004): Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161:12111218.
  • Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT (2006): Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 63:808816.
  • Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G (2001): Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21:RC141:14.
  • Carson RE, Barker WC, Liow JS, Johnson CA (2003): Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. In: IEEE Nuclear Science Symposium Conference Record, IEEE, Portland, OR, Vol. 1–5. pp. 32813285.
  • Christian BT, Vandehey NT, Floberg JM, Mistretta CA (2010): Dynamic PET denoising with HYPR processing. J Nucl Med 51:11471154.
  • Constantinescu CC, Yoder KK, Kareken DA, Bouman CA, O'Connor SJ, Normandin MD, Morris ED (2008): Estimation from PET data of transient changes in dopamine concentration induced by alcohol: Support for a non-parametric signal estimation method. Phys Med Biol 53:13531367.
  • Cox LS, Tiffany ST, Christen AG (2001): Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:716.
  • Di Chiara G, Imperato A (1988): Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:52745278.
  • Domino EF, Tsukada H (2009): Nicotine sensitization of monkey striatal dopamine release. Eur J Pharmacol 607:9195.
  • Endres CJ, Kolachana BS, Saunders RC, Su T, Weinberger D, Breier A, Eckelman WC, Carson RE (1997): Kinetic modeling of [11C]raclopride: Combined PET-microdialysis studies. J Cereb Blood Flow Metab 17:932942.
  • Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997): Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6:279287.
  • Hochberg Y, Tamhane AC. 1987. Multiple Comparison Procedures. Wiley, New York. 450 p.
  • Holmes AP, Blair RC, Watson JD, Ford I (1996): Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab 16:722.
  • Hughes JR, Hatsukami D (1986): Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289294.
  • Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003): Linearized reference tissue parametric imaging methods: Application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:10961112.
  • Lammertsma AA, Hume SP (1996): Simplified reference tissue model for PET receptor studies. Neuroimage 4 (Part 1):153158.
  • Lataster J, Collip D, Ceccarini J, Hernaus D, Haas D, Booij L, van Os J, Pruessner J, Van Laere K, Myin-Germeys I (2014): Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex. Schizophr Bull 40:6677.
  • Logan J, Dewey SL, Wolf AP, Fowler JS, Brodie JD, Angrist B, Volkow ND, Gatley SJ (1991): Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons. Synapse 9:195207.
  • Maisonneuve IM, Mann GL, Deibel CR, Glick SD (1997): Ibogaine and the dopaminergic response to nicotine. Psychopharmacology (Berl) 129:249256.
  • Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M (2001): Imaging human mesolimbic dopamine transmission with positron emission tomography. I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21:10341057.
  • Morris ED, Fisher RE, Alpert NM, Rauch SL, Fischman AJ (1995): In vivo imaging of neuromodulation using positron emission tomography: Optimal ligand characteristics and task length for detection of activation. Hum Brain Mapp 3:3555.
  • Morris ED, Yoder KK, Wang C, Normandin MD, Zheng QH, Mock B, Muzic RF Jr, Froehlich JC (2005): ntPET: A new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter release. Mol Imaging 4:473489.
  • Morris ED, Normandin MD, Schiffer WK (2008): Initial comparison of ntPET with microdialysis measurements of methamphetamine-induced dopamine release in rats: Support for estimation of dopamine curves from PET data. Mol Imaging Biol 10:6773.
  • Morris ED, Kim SJ, Sullivan JM, Wang S, Normandin MD, Constantinescu CC, Cosgrove KP (2013): Creating dynamic images of short-lived dopamine fluctuations with lp-ntPET: Dopamine movies of cigarette smoking. J Vis Exp. 78.
  • Muzic RF Jr, Cornelius S (2001): COMKAT: Compartment model kinetic analysis tool. J Nucl Med 42:636645.
  • Normandin MD, Morris ED (2008): Estimating neurotransmitter kinetics with ntPET: A simulation study of temporal precision and effects of biased data. Neuroimage 39:11621179.
  • Normandin MD, Schiffer WK, Morris ED (2012): A linear model for estimation of neurotransmitter response profiles from dynamic PET data. Neuroimage 59:26892699.
  • Pappata S, Dehaene S, Poline JB, Gregoire MC, Jobert A, Delforge J, Frouin V, Bottlaender M, Dolle F, Di Giamberardino L, and others (2002): In vivo detection of striatal dopamine release during reward: A PET study with [(11)C]raclopride and a single dynamic scan approach. Neuroimage 16:10151027.
  • Poline JB, Mazoyer BM (1993): Analysis of individual positron emission tomography activation maps by detection of high signal-to-noise-ratio pixel clusters. J Cereb Blood Flow Metab 13:425437.
  • Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996): Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255257.
  • Roland PE, Levin B, Kawashima R, Åkerman S (1993): Three-dimensional analysis of clustered voxels in 15O-butanol brain activation images. Hum Brain Mapp 1:319.
  • Sullivan JD, Kim S, Cosgrove KP, Morris ED (2013): Limitations of SRTM, Logan graphical method, and equilibrium analysis for measuring transient dopamine release with [11C]raclopride PET. Am J Nucl Med Mol Imaging 3:247260.
  • van Eimeren T, Ko JH, Pellechia G, Cho SS, Houle S, Strafella AP (2013): Prefrontal D2-receptor stimulation mediates flexible adaptation of economic preference hierarchies. Hum Brain Mapp 34:226232.
  • Volkow ND, Swanson JM (2003): Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160:19091918.
  • Votaw JR, Li HH (1995): Analysis of PET neurofunctional mapping studies. J Cereb Blood Flow Metab 15:492504.
  • Vrieze E, Ceccarini J, Pizzagalli DA, Bormans G, Vandenbulcke M, Demyttenaere K, Van Laere K, Claes S (2013): Measuring extrastriatal dopamine release during a reward learning task. Hum Brain Mapp 34:575586.